-
Impact of Cumulative Sleep Duration on Cardiac Structural Remodeling in Asymptomatic Adolescents. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-05 Carlos Real,Rocío Párraga,Jesús Martínez-Gómez,María Beneito-Dura,Ernesto González-Calvo,Raquel Diaz-Munoz,Paula Fernández-Acín,Eva Gutierrez-Ortiz,Miriam Garcia-Cocera,Javier Sánchez-González,Gonzalo Pizarro,Inés García-Lunar,Carlos Galán-Arriola,Juan Miguel Fernández-Alvira,Mercedes De Miguel,Amaya de Cos-Gandoy,Patricia Bodega,Leopoldo Pérez de Isla,Antonio Fernandez-Ortiz,Borja Ibáñez,Gloria Santos-Beneit
-
The Association Between Cardiac Symptoms and Coronary Plaque: An ADVANCE Substudy. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-03 Ruurt A Jukema,Philipp Blanke,John K Khoo,Georgios Tzimas,Aaisha Ferkh,Timothy Fairbairn,Koen Nieman,Manesh Patel,Bjarne L Nørgaard,Jonathon A Leipsic,
-
Global Practices in Cardiac Imaging for Cardiac Sarcoidosis: A Survey Study of International Experts With Delphi Consensus. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-01 Tahir S Kafil,Manuel L Ribeiro Neto,Marc A Judson,Leslie T Cooper,Jordana Kron,Jan C Grutters,David H Birnie,Ronald Witteles,Emer Joyce,Edward J Miller,Amit S Patel,Daniel A Culver,Christine L Jellis,
BACKGROUND Cardiac imaging is a cornerstone in the initial diagnosis, management, and follow-up of cardiac sarcoidosis. However, ordering thresholds, access, and follow-up imaging vary across the globe. OBJECTIVES A Delphi study was conducted to define areas of consensus and areas requiring further study in the use of cardiac imaging in suspected or established cardiac sarcoidosis. METHODS An international
-
Selection for Publication in JACC: Cardiovascular Imaging: Quality of Evidence. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-01 Thomas H Marwick,Leslee J Shaw,Y Chandrashekhar
-
Reply: Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in the Setting of Mitral Annular Disjunction. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-01 Pieter van der Bijl,Jan Stassen,Nina Ajmone Marsan,Jeroen J Bax
-
Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in the Setting of Mitral Annular Disjunction. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-01 Alon Shechter,Robert J Siegel
-
Racial Differences in Cardiovascular Mortality Among Patients in the Coronary Artery Calcium Consortium: Is it Race or Racism? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-06-01 Quinn Capers
-
Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-23 Frances M Wang,Shoshana H Ballew,Aaron R Folsom,Lynne E Wagenknecht,Candace M Howard,Josef Coresh,Matthew J Budoff,Michael J Blaha,Kunihiro Matsushita
BACKGROUND Our understanding of traditional atherosclerotic risk factors is based predominantly on one-time measurements and associations with adverse cardiovascular outcomes. OBJECTIVES The aim of this study was to evaluate the contribution of mid- to late-life cumulative risk factor exposure to healthy arterial aging, represented by a persistent coronary artery calcium (CAC) score of zero. METHODS
-
Echocardiographic Report Card 5 Years After Aortic Valve Replacement: TAVR Still Earning High Marks JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-14 Brian R. Lindman MD MSc, Bassim El-Sabawi MD
-
The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-14 Constantin-Cristian Topriceanu MD, Mashael Al-Farih PhD, George Joy MBBS PhD, Fiona Chan MBBS, Matt Webber MBChB PhD, Denis C. Ilie-Ablachim PhD, Hunain Shiwani BMBS, Mansoon Tamang BSc, Catherine Banks BSc, Stephen Pettit MD PhD, Steffen E. Petersen MBChB MD(Res) DPhil (Oxon) MPH, Ben O’Brien MD, Alun D. Hughes PhD, Iain Pierce PhD, William E. Moody MBChB PhD, Richard P. Steeds MBBS MD, Paolo E. Puddu
Lamin (LMNA) heart disease is a lethal form of dilated cardiomyopathy (DCM).
-
Early Phenotype Identification: The Key to Taming Genetic Cardiomyopathies JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-14 Karolina M. Zareba MD, Ray E. Hershberger MD
-
Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-13 René R Sevag Packard,Matthieu Pelletier-Galarneau,Saurabh Malhotra,Sharmila Dorbala,Wengen Chen,Vasken Dilsizian
Positron emission tomography (PET)/computed tomography is a major imaging strategy for cardiovascular disease characterization. Whereas multiple radioisotopes can be used for PET imaging of cardiac disease processes, fluorine-18 (18F) presents key advantages. These include availability as a unit dose given a favorable half-life of 109.7 minutes and a short positron range leading to a high spatial resolution
-
Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography/Computed Tomography. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-13 Dia A Smiley,Andrew J Einstein,Kevin J O'Gorman,Denisse Santana,Sergio Teruya,Nicholas Chan,Ani Nalbandian,Timothy J Poterucha,Stephen T Helmke,Akiva Mintz,Kim Goldner,Miroslav Sekulic,Alfonsina Mirabal,Margaret O Cuomo,Samantha Guadalupe,Jeffeny De Los Santos,Mary E Paulino,Kimberly A Mateo,Carlos M Rodriguez,Massiel Jimenez,Abdirahman Wardhere,Dimitrios Bampatsias,Michelle Castillo,Boyu Peng,Mathew
BACKGROUND Early detection of transthyretin cardiac amyloidosis (ATTR-CA) is vital, because currently available therapies are most effective early in the disease course. Although Perugini grade 2 or 3 uptake on scintigraphy using bone-avid tracers such as 99mTc-pyrophosphate is highly specific for ATTR-CA, absent monoclonal proteins, sensitivity is about 70%. Positron emission tomographic (PET)/computed
-
Long-Term Left Atrial Function After Device Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-12 Teresa Gil-Jiménez,Rocío García-Orta,Inmaculada Villegas-Rodríguez,Juan Caballero-Borrego,Eduardo Moreno-Escobar
-
Severe Aortic Stenosis With High Noncalcific Aortic Valve Volume: A Novel Marker of Myocardial Fibrosis. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-08 Davide Margonato,Hideki Koike,Miho Fukui,Takahiro Nishihara,Felipe Kazmirczak,Victor Cheng,John Lesser,Marc R Dweck,Maurice Enriquez-Sarano,João L Cavalcante
-
Good FFRCT Test-Retest Reproducibility: The Importance of High Coronary CT Angiography Image Quality. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-07 Nadia Iraqi,Martin Bødtker Mortensen,Niels Peter Rønnow Sand,Martin Busk,Kristian Tækker Madsen,Erik Lerkevang Grove,Kamilla Bech Pedersen,Helle Kanstrup,Timothy A Fairbairn,Erik Parner,Jesper Møller Jensen,Bjarne Linde Nørgaard
-
The Underrepresentation of Women Among Cardiac Imagers: An Analysis of Cardiologists Based on Medicare Part B Data, 2013-2022. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-03 Maria Alwan,Ahmed Sayed,Nadeen N Faza,Chiara Bucciarelli-Ducci,Panithaya Chareonthaitawee,Ahmad El Yaman,Asim Shaikh,Mahmoud Al Rifai,Mouaz H Al-Mallah
-
Photon-Counting Detector Computed Tomography: Shaking Up the Status Quo. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 Pál Maurovich-Horvat,Emese Zsarnóczay
-
Expanding Our Understanding of Plaque Stabilization With PCSK9 Inhibitors. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 Stephen J Nicholls,Emily G Nicholls
-
Searching for Insights Into the Timing of Intervention in Aortic Regurgitation Using Machine Learning. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 Rhodri H Davies,Thomas A Treibel
-
How Low Can You Go: Finally a Lower Limit of Normality? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 James D Thomas,Vinesh Appadurai
-
Photon-Counting Detector Coronary CT Angiography: A Confidence Booster for Bloomy Vessels. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 Koen Nieman,Y Chandrashekhar
-
Did You Check Diastolic Function During Cancer Treatment?: It's Not Just Systole's Show. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-05-01 Ana Barac,Tiffany L Brazile
-
Building Consensus on Advanced Imaging in Cardiac Sarcoidosis. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-30 Sanjay Divakaran,Garrick C Stewart
-
Comprehensive Lesion Assessment for the Prediction of Acute Coronary Syndrome: It's About Time. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-30 Andrew Lin,Nitesh Nerlekar
-
Statin Therapy Persistence Following Opportunistic Screening for Coronary Artery Calcium on Nongated Chest CTs: NOTIFY-EXTEND. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-30 Sarkis G Bouladian,Summer Ngo,Domenico Mastrodicasa,David Eng,Nishith Khandwala,Doug Sousa,Akshay S Chaudhari,David J Maron,Fatima Rodriguez,Alexander T Sandhu
-
Valve Area Planimetry on 4D-CT for Significant Aortic Stenosis: Correlations With Echocardiography and Optimal Thresholds. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-28 Aro Daniela Arockiam,Akiva Rosenzveig,Tiffany Dong,Elio Haroun,Ankit Agrawal,Joseph El Dahdah,Rishabh Khurana,Aritra Paul,Odette Iskandar,Bianca Honnekeri,Jaideep Singh Bhalla,Agam Bansal,Serge Harb,Zoran Popovic,Leonardo Rodriguez,Brian Griffin,Samir Kapadia,Tom Kai Ming Wang
-
Association of PM2.5 With Cardiac Mechanics Using Speckle-Tracking Echocardiography in the Cardiovascular Health Study JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-16 Andrew Y. Chang MD PhD, Joel D. Kaufman MD MPH, Annabel Xulin Tan MPH PhD, Sanjiv J. Shah MD, Ravi B. Patel MD MS, Helene Margolis PhD, Bruce M. Psaty MD PhD, Julius M. Gardin MD MBA, Sadeer Al-Kindi MD, Thomas R. Austin PhD, Michelle C. Odden PhD
-
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-16 Rebecca T. Hahn MD, Julien Ternacle MD PhD, Iria Silva MD, Carlos Giuliani MD, Antonela Zanuttini MD, Alexis Théron MD, Nicole Cristell MD, Mathieu Bernier MD, Sabah Skaf MD, Jonathan Beaudoin MD, Susheel K. Kodali MD, Mark Russo MD, Samir R. Kapadia MD, Chris S. Malaisrie MD, David J. Cohen MD MSc, Jonathon Leipsic MD, Philipp Blanke MD, Mathew R. Williams MD, James M. McCabe MD, David L. Brown MD
The PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients with Aortic Stenosis) trial compared SAPIEN 3 transcatheter aortic valve replacement (TAVR) to surgery in low-risk patients with symptomatic, severe aortic stenosis. Echocardiographic outcomes at 5 years are unknown.
-
Prognostic Time Frame of Plaque and Hemodynamic Characteristics and Integrative Risk Prediction for Acute Coronary Syndrome. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-10 Seokhun Yang,Jae Wook Jung,Sang-Hyeon Park,Jinlong Zhang,Keehwan Lee,Doyeon Hwang,Kyu-Sun Lee,Sang-Hoon Na,Joon-Hyung Doh,Chang-Wook Nam,Tae Hyun Kim,Eun-Seok Shin,Eun Ju Chun,Su-Yeon Choi,Hyun Kuk Kim,Young Joon Hong,Hun-Jun Park,Song-Yi Kim,Mirza Husic,Jess Lambrechtsen,Jesper M Jensen,Bjarne L Nørgaard,Daniele Andreini,Pal Maurovich-Horvat,Bela Merkely,Martin Penicka,Bernard de Bruyne,Abdul Ihdayhid
BACKGROUND The relevant time frame for predicting future acute coronary syndrome (ACS) based on coronary lesion characteristics remains uncertain. OBJECTIVES The aim of this study was to investigate the association of lesion characteristics with test-to-event time and their prognostic impact on ACS. METHODS The EMERALD II (Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary
-
Racial and Ethnic Differences in Long-Term Cardiovascular Mortality Among Women and Men From the CAC Consortium JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-09 Shmuel Rosenblatt BS, Michael J. Blaha MD MPH, Ron Blankstein MD, Khurram Nasir MD MPH, Fay Lin MD, Yvette Yeboah-Kordieh MBChB MPH, Daniel S. Berman MD, Michael D. Miedema MD MPH, Seamus P. Whelton MD MPH, John Rumberger MD, Matthew J. Budoff MD, Jonathon Leipsic MD, Leslee J. Shaw PhD
Despite an increasingly diverse population, knowledge regarding racial and ethnic disparities is limited among women and men undergoing atherosclerotic cardiovascular (ASCVD) risk assessment.
-
Racial and Ethnic Differences Among Patients Referred for Noninvasive Coronary Artery Disease Evaluation JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-04 Catherine X. Wright MD, Erica S. Spatz MD MHS, Edward J. Miller MD PhD, Attila Feher MD PhD
-
Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-02 Donghee Han MD, Evangelos Tzolos MD, Rebekah Park MS, Heidi Gransar MS, Mark Hyun CMNT, John D. Friedman MD, Sean W. Hayes MD, Louise E.J. Thomson MBChB, Alan C. Kwan MD, Matthew Budoff MD, Prediman K. Shah MD, Jacek Kwieciński MD, Sarah Wetzel BS, Chloe Findling BA, Piotr J. Slomka PhD, Damini Dey PhD, Balaji K. Tamarappoo MD PhD, Daniel S. Berman MD
The effects of evolocumab on the underlying coronary disease activity by positron emission tomography (PET) and coronary tree plaque composition by coronary computed tomography angiography (CTA) have not been described.
-
Thresholds for Intervention in Valve Disease: Does the Evidence Support Lowering? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Thomas H Marwick,Y Chandrashekhar
-
Toward a Standardized Threshold of Global Longitudinal Strain in Asymptomatic Aortic Regurgitation. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Simon Leboube,Denise Auberson,Georgios Tzimas,Pierre Monney,Panagiotis Antiochos
-
Reply: Toward a Standardized Threshold of Global Longitudinal Strain in Asymptomatic Aortic Regurgitation. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Vidhu Anand,Hector I Michelena,Alex T Lee,Christopher G Scott,Patricia A Pellikka
-
Streamlined Imaging and Procedural Workflow for Tricuspid Transcatheter Edge-to-Edge Repair. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Lin Wang,Billal Tokhi,George A Petrossian,William B Chung,Omar Khalique,David J Cohen,Jaffar M Khan
-
Outcomes in Patients Undergoing TAVR Planning with Contrast-Enhanced CT vs Noncontrast CT and CMR. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Besir Besir,Judah Rajendran,Shivabalan Kathavarayan Ramu,Maryam Muhammad Ali Majeed-Saidan,Aditya Mantha,Rishi Puri,Grant W Reed,James Yun,Amar Krishnaswamy,Serge C Harb,Samir R Kapadia
-
Number Needed to Defeat?: Overcoming Barriers to Optimal Coronary Disease Screening With CT Calcium Scoring. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Philip Greenland,Kim A Williams
-
Chronic Aortic Regurgitation: A Call for Re-Action. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-04-01 Akhil Narang,James D Thomas,Robert O Bonow
-
The Last Decade in Tricuspid Regurgitation: How Imaging Shaped a Field JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-29 Rebecca T. Hahn MD, Luigi Badano MD PhD, Fabien Praz MD, Denisa Muraru MD PhD, Eustachio Agricola MD, Nina Ajmone Marsan MD PhD, Joanna Bartkowiak MD, Victoria Delgado MD PhD, Julien Dreyfus MD PhD, Jörg Hausleiter MD, Philipp Lurz MD, Francesco Maisano MD, Davide Margonato MD, David Messika-Zeitoun MD PhD, Maurice Enriquez-Sarano MD, João L. Cavalcante MD
The tricuspid valve has become a major focus of novel structural heart interventions, with the Conformité Européenne approval of 5 devices in Europe and the U.S. Food and Drug Administration approval of 2 devices in the United States. Multiple meta-analyses and large population-based registries have shown that although significant tricuspid regurgitation (TR) often accompanies left heart or pulmonary
-
Machine Learning Identification of Patient Phenoclusters in Aortic Regurgitation JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-26 Maan Malahfji MD, Xin Tan BS, Yodying Kaolawanich MD, Mujtaba Saeed MD, Andrada Guta MD, Michael J. Reardon MD, William A. Zoghbi MD, Venkateshwar Polsani MD, Michael Elliott MD, Raymond Kim MD, Meng Li PhD, Dipan J. Shah MD
Current treatment paradigms assume aortic regurgitation (AR) patients to be a homogenous population, but varied courses of disease progression and outcomes are observed clinically.
-
Prognostic Relevance and Lower Limit of the Reference Range of Left Ventricular Global Longitudinal Strain: A Clinical Validation Study JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-19 Daniel A. Morris MD, Chung-Lieh Hung MD, Tor Biering-Sørensen MD, Tatiana Kuznetsova MD, Erwan Donal MD, Wojciech Kosmala MD, Masaaki Takeuchi MD, Roberto Lang MD, Marijana Tadic MD, Chun-Yan Ma MD, Evgeny Belyavskiy MD, Henryk Dreger MD, Matthias Schneider-Reigbert MD, Athanasios Frydas MD
The lower limit of the reference normal range (LLN) of left ventricular global longitudinal strain (GLS) for each ultrasound software vendor and its prognostic relevance in the elderly and in asymptomatic patients at risk for heart failure (HF) remain uncertain.
-
Can Vulnerable Plaque Imaging PREVENT Cardiovascular Events? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-19 Stephen J. Nicholls MBBS PhD, Adam J. Nelson MBBS PhD
-
Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in Women With Early-Stage Breast Cancer JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-19 Flora Huang MD, Kate Rankin MBBS, Maala Sooriyakanthan BSc (Hons) RDCS, Marisa Signorile MMath, Chun-Po Steve Fan PhD, Babitha Thampinathan RDCS, Thomas H. Marwick MD PhD MPH, Nichanan Osataphan MD, Christopher Yu MBBS PhD, C. Anne Koch MD PhD, Eitan Amir MD PhD, Kate Hanneman MD MPH, Husam Abdel-Qadir MD PhD, Bernd J. Wintersperger MD, Paaladinesh Thavendiranathan MD SM
Understanding phenotypic variations in left ventricular (LV) dysfunction during cancer therapy may allow for tailored surveillance and prevention.
-
Cardiac Imaging Trends: A Decade of Medicare Data JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-12 Ahmed Sayed MD, Mahmoud Al Rifai MD MPH, Maria Alwan MD, Ahmad El Yaman MD, Asim Shaikh MD, William Zoghbi MD, Mouaz H. Al-Mallah MD MSc
-
Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-05 Jelena Pavlović MD MSc, Daniel Bos MD PhD, M. Kamran Ikram MD PhD, M. Arfan Ikram MD PhD, Maryam Kavousi MD PhD, Maarten J.G. Leening MD PhD
The 2018 ACC (American College of Cardiology)/AHA (American Heart Association) and 2021 ESC (European Society of Cardiology)/EAS (European Atherosclerosis Society) guidelines recommend coronary artery calcium (CAC) score for risk refinement in primary prevention of atherosclerotic cardiovascular disease (ASCVD).
-
-
-
Reply: Low-Flow Low-Gradient Aortic Stenosis: Is It Merely a Pathology of the Aortic Valve and Left Ventricle? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Adrian Chong MBBS BPharm, Jonathan Sen MBBS BHSc, Thomas H. Marwick MBBS PhD MPH
-
Coronary Calcium in the Last Decade: Where Are We Now JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Ron Blankstein MD, Leslee J. Shaw PhD, Y. Chandrashekhar MD DM
-
Timing of Intervention in Aortic Regurgitation: Steering Management Beyond Current Guideline Indications JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 William A. Zoghbi MD, Maan Malahfji MD
-
Low-Flow Low-Gradient Aortic Stenosis: Is It Merely a Pathology of the Aortic Valve and Left Ventricle? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Ali Dahhan MD, Mohammad Bilal Memon DO, Zachariah Zaaza DO, Ramtin Khanipour MD, Hanan Gruhonjic MD
-
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Giuseppe Vergaro MD PhD, Alberto Aimo MD PhD, Dario Genovesi MD, Assuero Giorgetti MD, Michele Emdin MD PhD
-
Reply: Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Olivier F. Clerc MD MPH, Sharmila Dorbala MD MPH
-
Keeping Up With the Times: The Use of a Vision Transformer for Identifying Cardiac Amyloidosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Alan C. Kwan MD, David Ouyang MD
-
Activated Fibroblast Imaging in AL Amyloid Cardiomyopathy: A Window Into the Extracellular Space JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Rodney H. Falk MD, Osnat Itzhaki Ben Zadok MD
-
Intraprocedural Guidance for Transcatheter Tricuspid Valve Replacement in Challenging Scenarios JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-03-03 Lucy M. Safi DO, Stamatios Lerakis MD PhD, Gilbert H.L. Tang MD MSc MBA, Annapoorna S. Kini MD, Parasuram Krishnamoorthy MD, Samin K. Sharma MD, Sahil Khera MD MPH
-
The Double Dyssynchrony Paradox: When Cardiac Discord Signals Hope JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-02-26 Joost Lumens PhD
-
Vulnerable or High-Risk Plaque: A JACC: Cardiovascular Imaging Position Statement JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-02-26 Rocco Vergallo MD PhD, Seung-Jung Park MD PhD, Gregg W. Stone MD, David Erlinge MD PhD, Italo Porto MD PhD, Ron Waksman MD, Gary S. Mintz MD, Fabrizio D’Ascenzo MD PhD, Sara Seitun MD, Luca Saba MD, Rozemarijn Vliegenthart MD PhD, Fernando Alfonso MD, Armin Arbab-Zadeh MD PhD MPH, Peter Libby MD, Marcelo F. Di Carli MD, James E. Muller MD, Gerald Maurer MD, Robert J. Gropler MD, Y.S. Chandrashekhar
The concept of high-risk plaque emerged from pathologic and epidemiologic studies 3 decades ago that demonstrated plaque rupture with thrombosis as the predominant mechanism of acute coronary syndrome and sudden cardiac death. Thin-cap fibroatheroma, a plaque with a large lipidic core covered by a thin fibrous cap, is the prototype of the rupture-prone plaque and has been traditionally defined as “vulnerable